search
Penn Medicine
Trends
- 1Penn Medicine and IBA Launch Global Proton Therapy Venture●Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
Penn Medicine and IBA have announced a joint venture aimed at advancing proton therapy and radiation oncology program development worldwide. The partnership will combine the University of Pennsylvania health system's clinical expertise with the Belgian company's proton therapy technology to help institutions globally develop advanced cancer treatment programs. The news was picked up by international outlets including The Manila Times, reflecting interest in the global expansion of this cancer care technology.
- 2IBA and Penn Medicine Launch Noventra Oncology Joint Venture▼IBA, Penn Medicine Announce Noventra Oncology Alliance Joint Venture
IBA and Penn Medicine have announced the creation of Noventra Oncology Alliance, a joint venture focused on oncology. The partnership combines IBA's technology background with Penn Medicine's clinical and research expertise to develop and advance cancer treatment solutions. Details on funding, leadership and the venture's first programs have not yet been made public.